Subscribe To
cullinan oncology posts updated data for cln-081 in nsclc egfr exon 20 patients
cullinan Oncology Inc (NASDAQ: CGEM) reported updated data from its ongoing Phase 1/2a trial of CLN-...
December 16, 2021, 1:04 pm
cullinan oncology posts updated data for cln-081 in nsclc egfr exon 20 patients
cullinan Oncology Inc (NASDAQ: CGEM) reported updated data from its ongoing Phase 1/2a trial of CLN-...
December 16, 2021, 1:04 pm
cullinan oncology posts updated data for cln-081 in nsclc egfr exon 20 patients
cullinan Oncology Inc (NASDAQ: CGEM) reported updated data from its ongoing Phase 1/2a trial of CLN-...
December 16, 2021, 1:04 pm